| 30/09/26 | 13:00:00 | 30 Sept 2026 | | Interim Results for the Six Months to June 30, 2026, and Business Update | GNW |
| 25/09/26 | 07:00:00 | 25 Sept 2026 | | The FOCUS-01 Clinical Trial Design and Preclinical Data Further Demonstrate the Potential of AVA6103 at AACR Conference on Pancreatic Cancer | GNW |
| 16/09/26 | 16:00:00 | 16 Sept 2026 | | Avacta Achieves Clinical Proof of Mechanism for the Next Generation of pre|CISION® Medicines with AVA6103 (FAP-Exd) in the Phase 1 FOCUS-01 Trial | GNW |
| 14/09/26 | 07:00:00 | 14 Sept 2026 | | Avacta Appoints Mats Blom to the Board of Directors as Chair of Audit Committee | GNW |
| 08/07/26 | 07:00:00 | 8 Jul 2026 | | Avacta Appoints Healthcare Executive Patrick Vink as Deputy Chairman of the Board of Directors | GNW |
| 01/06/26 | 07:00:00 | 1 Jun 2026 | | Avacta presents updated clinical data showing encouraging early efficacy signals for AVA6000 in salivary gland cancers at ASCO 2026 | GNW |
| 19/05/26 | 07:14:00 | 19 May 2026 | | Unaudited Preliminary Results for the Year Ended December 31, 2025 | GNW |
| 06/05/26 | 07:00:00 | 6 May 2026 | | Avacta presents new comparisons of pre|CISION® payload release vs approved ADCs and AVA6207 dual payload delivery at Science Day 2026 | GNW |
| 21/04/26 | 17:00:00 | 21 Apr 2026 | | Avacta data at AACR 2026 underline favorable profile of AVA6103 and advantages of pre|CISION® delivery platform | GNW |
| 18/11/21 | 16:36:03 | 18 Nov 2021 | | Price Monitoring Extension | RNS |
| 02/11/21 | 07:00:04 | 2 Nov 2021 | | Update on UK Availability of AffiDX Test | RNS |
| 14/10/21 | 16:36:18 | 14 Oct 2021 | | Price Monitoring Extension | RNS |
| 14/10/21 | 12:36:04 | 14 Oct 2021 | | Issue of Equity and Total Voting Rights | RNS |
| 30/09/21 | 07:00:10 | 30 Sept 2021 | | Interim Results for the Period Ended 30 June 2021 | RNS |
| 29/09/21 | 07:00:09 | 29 Sept 2021 | | Development Milestone in LG Chem Partnership | RNS |
| 22/09/21 | 16:41:15 | 22 Sept 2021 | | Second Price Monitoring Extn | RNS |
| 22/09/21 | 16:35:57 | 22 Sept 2021 | | Price Monitoring Extension | RNS |
| 09/09/21 | 07:00:07 | 9 Sept 2021 | | Notice of Results | RNS |
| 06/09/21 | 07:00:08 | 6 Sept 2021 | | New appointments to Scientific Advisory Board | RNS |
| 02/09/21 | 07:00:09 | 2 Sept 2021 | | Appointment of Chief Scientific Officer | RNS |
| 25/08/21 | 16:40:49 | 25 Aug 2021 | | Second Price Monitoring Extn | RNS |
| 25/08/21 | 16:35:49 | 25 Aug 2021 | | Price Monitoring Extension | RNS |
| 18/08/21 | 07:00:06 | 18 Aug 2021 | | Directorate Change | RNS |
| 11/08/21 | 07:00:10 | 11 Aug 2021 | | First Patient Dosed in AVA6000 Phase 1 Trial | RNS |
| 04/08/21 | 07:00:04 | 4 Aug 2021 | | Update on AffiDX Lateral Flow Test | RNS |
| 14/07/21 | 07:00:03 | 14 Jul 2021 | | Diagnostics achieves ISO 13485 Certification | RNS |
| 12/07/21 | 16:41:14 | 12 Jul 2021 | | Second Price Monitoring Extn | RNS |
| 12/07/21 | 16:35:36 | 12 Jul 2021 | | Price Monitoring Extension | RNS |
| 29/06/21 | 07:00:03 | 29 Jun 2021 | | AffiDX Lateral Flow Test Detects Delta Variant | RNS |
| 28/06/21 | 12:13:34 | 28 Jun 2021 | | Result of AGM | RNS |
| 21/06/21 | 14:05:51 | 21 Jun 2021 | | Second Price Monitoring Extn | RNS |
| 21/06/21 | 14:00:24 | 21 Jun 2021 | | Price Monitoring Extension | RNS |
| 21/06/21 | 07:00:08 | 21 Jun 2021 | | AffiDX Lateral Flow Test Distribution Agreement | RNS |
| 15/06/21 | 08:00:03 | 15 Jun 2021 | | Issue of Equity and Total Voting Rights | RNS |
| 11/06/21 | 14:05:57 | 11 Jun 2021 | | Second Price Monitoring Extn | RNS |
| 11/06/21 | 14:00:59 | 11 Jun 2021 | | Price Monitoring Extension | RNS |
| 11/06/21 | 11:07:16 | 11 Jun 2021 | | Registration of AffiDX Lateral Flow Test in EU | RNS |
| 09/06/21 | 09:08:53 | 9 Jun 2021 | | Holding(s) in Company | RNS |
| 07/06/21 | 07:00:12 | 7 Jun 2021 | | MHRA Confirms Registration of Lateral Flow Test | RNS |
| 01/06/21 | 07:00:12 | 1 Jun 2021 | | Update on Lateral Flow Test Regulatory Submissions | RNS |
| 28/05/21 | 07:00:08 | 28 May 2021 | | Response to speculation | RNS |
| 25/05/21 | 10:00:07 | 25 May 2021 | | Posting of Annual Report and Notice of AGM | RNS |
| 10/05/21 | 10:36:35 | 10 May 2021 | | AffiDX SARS-CoV-2 Antigen Lateral Flow Test Update | RNS |
| 06/05/21 | 07:00:05 | 6 May 2021 | | Change of Nominated Adviser | RNS |
| 30/04/21 | 12:37:10 | 30 Apr 2021 | | Issue of Equity | RNS |
| 28/04/21 | 17:18:55 | 28 Apr 2021 | | Issue of Equity | RNS |
| 28/04/21 | 16:41:22 | 28 Apr 2021 | | Second Price Monitoring Extn | RNS |
| 28/04/21 | 16:36:12 | 28 Apr 2021 | | Price Monitoring Extension | RNS |
| 22/04/21 | 07:00:03 | 22 Apr 2021 | | Final Results | RNS |
| 20/04/21 | 11:05:39 | 20 Apr 2021 | | Second Price Monitoring Extn | RNS |
